Back to top
Celvestrant 250 mg PFS
Celvestrant 250 mg PFS

Celvestrant 250 mg PFS

Celvestrant 250 mg PFS Specification

  • Pacakaging (Quantity Per Box)
  • 1 Pre-filled Syringe
  • Origin of Medicine
  • Synthetic
  • Salt Composition
  • Fulvestrant
  • Drug Type
  • Anticancer Drug
  • Ingredients
  • Fulvestrant 250 mg
  • Physical Form
  • Pre-filled Syringe (PFS)
  • Function
  • Hormonal Therapy for Breast Cancer
  • Recommended For
  • Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer
  • Dosage
  • 250 mg administered intramuscularly
  • Dosage Guidelines
  • Administer 250 mg every two weeks for the first three doses followed by 250 mg once monthly thereafter
  • Suitable For
  • Adults specifically postmenopausal women
  • Quantity
  • 1 syringe per box
  • Storage Instructions
  • Store refrigerated at 2C to 8C (36F to 46F) do not freeze and protect from light
 
 

About Celvestrant 250 mg PFS



Celvestrant 250 mg PFS is a potent Anticancer Drug containing 250 mg of Fulvestrant in each Pre-filled Syringe (PFS). It is designed for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer. This synthetic medication is administered intramuscularly with a dosage of 250 mg every two weeks for the first three doses followed by 250 mg monthly. Each box contains 1 syringe and should be stored refrigerated at 2C to 8C, protected from light.

FAQs of Celvestrant 250 mg PFS:


Q: What is Celvestrant 250 mg PFS used for?

A: Celvestrant 250 mg PFS is used for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer.

Q: How should Celvestrant 250 mg PFS be stored?

A: Celvestrant 250 mg PFS should be stored refrigerated at 2C to 8C, and protected from light.

Q: What is the dosage recommendation for Celvestrant 250 mg PFS?

A: The recommended dosage is 250 mg administered intramuscularly every two weeks for the first three doses, followed by 250 mg monthly thereafter.

Q: Is Celvestrant 250 mg PFS suitable for all adults?

A: Celvestrant 250 mg PFS is specifically suitable for postmenopausal women.

Q: What is the salt composition of Celvestrant 250 mg PFS?

A: The salt composition of Celvestrant 250 mg PFS is Fulvestrant.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Lipodox 20 mg Injection

Lipodox 20 mg Injection

Drug Type : Other, Anticancer

Quantity : 1 vial

Recommended For : Patients with breast cancer ovarian cancer and Kaposis sarcoma

Salt Composition : Doxorubicin Hydrochloride Liposomal

Dosage : 20 mg

Dosage Guidelines : Administered intravenously under the supervision of a healthcare specialist dosage varies based on patient condition

Geffy 250 mg Tablet

Geffy 250 mg Tablet

Drug Type : Other, Tablet

Quantity : 1 strip (usually contains 10 tablets)

Recommended For : Patients diagnosed with nonsmall cell lung cancer

Salt Composition : Gefitinib

Dosage : 250 mg per day or as directed by the physician

Dosage Guidelines : Should be taken orally with water with or without food; follow the doctors instructions

Glenstime PEG 6 mg PFS

Glenstime PEG 6 mg PFS

Drug Type : Injectable, Other

Quantity : 1 prefilled syringe

Recommended For : Adults requiring PEGbased therapeutic support

Salt Composition : Polyethylene glycol compound in a 6 mg strength

Dosage : 6 mg per syringe

Dosage Guidelines : As prescribed by the physician; typically administered under medical supervision

Evermil 10 mg Tablet

Evermil 10 mg Tablet

Drug Type : Pharmaceutical, Other

Quantity : 10 tablets per strip

Recommended For : Patients with specific types of cancer (e.g. breast kidney neuroendocrine) and organ transplant recipients

Salt Composition : Everolimus

Dosage : 10 mg once daily or as directed by a physician

Dosage Guidelines : Take orally with or without food and follow the physicians prescription closely